AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 20151971 — intervention group
Group type: COMPARATOR
Intervention: Placebo (in subset with ED)
Number of subjects: 310
Study 18201612 — intervention group
Group type: EXPERIMENTAL
Intervention: 10% activated PRP (0.38x increase in platelet count)
Number of subjects: 1
Study 18201612 — intervention group
Group type: EXPERIMENTAL
Intervention: 25% activated PRP (0.95x increase in platelet count)
Number of subjects: 1
Study 18201612 — intervention group
Group type: EXPERIMENTAL
Intervention: Activated PRP (10% and 25%)
Number of subjects: 1
Study 18201612 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonactivated PRP
Number of subjects: 1
Study 18201612 — intervention group
Group type: COMPARATOR
Intervention: Control group (without PRP)
Number of subjects: 1
Study 16437657 — intervention group
Group type: EXPERIMENTAL
Intervention: 5‐ASA (50 mg/kg/d) + omega‐3 FAs (3 g/d, EPA 400 mg/g, DHA 200 mg/g)
Number of subjects: 38
Study 16437657 — intervention group
Group type: COMPARATOR
Intervention: 5‐ASA (50 mg/kg/d) + olive oil placebo capsules
Number of subjects: 38
Study 12706010 — intervention group
Group type: EXPERIMENTAL
Intervention: Computed tomography osteoabsorptiometry in cuff tear shoulders
Number of subjects: 19
Study 12706010 — intervention group
Group type: COMPARATOR
Intervention: Computed tomography osteoabsorptiometry in normal shoulders
Number of subjects: 19
Study 10753002 — intervention group
Group type: EXPERIMENTAL
Intervention: Metrifonate 30-60 mg
Number of subjects: 1277
Study 10753002 — intervention group
Group type: EXPERIMENTAL
Intervention: Metrifonate 60/80 mg
Number of subjects: 1277
Study 10753002 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1277
Study 8604957 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorhexidine mouth rinse
Number of subjects: 70
Study 8604957 — intervention group
Group type: COMPARATOR
Intervention: Placebo mouth rinse
Number of subjects: 70
Study 8604957 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorhexidine and Placebo
Number of subjects: 70
Study 1421640 — intervention group
Group type: EXPERIMENTAL
Intervention: Heparin sodium 1000 units/mL
Number of subjects: 81
Study 1421640 — intervention group
Group type: COMPARATOR
Intervention: NaCl 0.9%
Number of subjects: 81
Study 6399890 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral frusemide/amiloride combination tablet (40 mg frusemide and 5 mg amiloride)
Number of subjects: 12
Study 6399890 — intervention group
Group type: COMPARATOR
Intervention: Commercially-available 40 mg frusemide tablets
Number of subjects: 12
Study 6399890 — intervention group
Group type: COMPARATOR
Intervention: Commercially-available 5 mg amiloride tablets
Number of subjects: 12
Study 31033190 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol treatment in PEAR-2 study
Number of subjects: 434
Study 31033190 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol treatment in PEAR study
Number of subjects: 434
Study 31033190 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol add-on cohort
Number of subjects: 434
Study 30397007 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture at 'four sacral points' along with routine medical care
Number of subjects: 140
Study 30397007 — intervention group
Group type: COMPARATOR
Intervention: Conventional electroacupuncture along with routine medical care
Number of subjects: 140
Study 27736850 — intervention group
Group type: EXPERIMENTAL
Intervention: Paracetamol
Number of subjects: 1806
Study 27736850 — intervention group
Group type: COMPARATOR
Intervention: Ibuprofen
Number of subjects: 1806
Study 27736850 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 1806
Study 27736850 — intervention group
Group type: EXPERIMENTAL
Intervention: Postnatal recruitment
Number of subjects: 1806
Study 24511022 — intervention group
Group type: EXPERIMENTAL
Intervention: S-1 plus irinotecan (SIri)
Number of subjects: 102
Study 24511022 — intervention group
Group type: COMPARATOR
Intervention: S-1 plus paclitaxel (SPac)
Number of subjects: 102
Study 22892323 — intervention group
Group type: EXPERIMENTAL
Intervention: ezetimibe 10 mg/day + statin
Number of subjects: 150
Study 22892323 — intervention group
Group type: COMPARATOR
Intervention: double-dose statin
Number of subjects: 150
Study 20181994 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical Activity (PA) intervention
Number of subjects: 213
Study 17673615 — intervention group
Group type: EXPERIMENTAL
Intervention: Erlotinib
Number of subjects: 0
Study 11281486 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefazolin 1 g intravenously after induction of anesthesia (PA group)
Number of subjects: 102
Study 11281486 — intervention group
Group type: COMPARATOR
Intervention: No prophylactic antibiotics (NONE group)
Number of subjects: 102
Study 9374260 — intervention group
Group type: EXPERIMENTAL
Intervention: Polyacrylic acid 0.2% (PAA)
Number of subjects: 85
Study 9374260 — intervention group
Group type: COMPARATOR
Intervention: Polyvinylalcohol 1.4% (PVA)
Number of subjects: 85
Study 8338261 — intervention group
Group type: EXPERIMENTAL
Intervention: 35 ml of 1.5% lidocaine with 1 in 200,000 of adrenaline (Group A)
Number of subjects: 13
Study 8338261 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 microgram.kg‐1 of fentanyl with the same dose of lidocaine (Group B)
Number of subjects: 13
Study 3525976 — intervention group
Group type: EXPERIMENTAL
Intervention: Antazoline (Antistine) in addition to conventional immunosuppressive therapy (group A)
Number of subjects: 69
Study 3525976 — intervention group
Group type: COMPARATOR
Intervention: Conventional immunosuppressive therapy only (group B)
Number of subjects: 69
Study 31665935 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranibizumab 0.5 mg PRN
Number of subjects: 487
Study 31665935 — intervention group
Group type: COMPARATOR
Intervention: Dexamethasone 0.7 mg implant
Number of subjects: 487
Study 28224313 — intervention group
Group type: EXPERIMENTAL
Intervention: Black gay male stereotypes
Number of subjects: 285
Study 28224313 — intervention group
Group type: COMPARATOR
Intervention: Stereotypes of Black men
Number of subjects: 285
Study 28224313 — intervention group
Group type: COMPARATOR
Intervention: Stereotypes of gay men
Number of subjects: 285
Study 28224313 — intervention group
Group type: EXPERIMENTAL
Intervention: Unique stereotypes of Black MSM
Number of subjects: 285
Study 27189899 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational programme with telephone reinforcement
Number of subjects: 108
Study 27189899 — intervention group
Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 108
Study 24454875 — intervention group
Group type: EXPERIMENTAL
Intervention: Government of Kenya's Cash Transfer for Orphans and Vulnerable Children (Kenya CT‐OVC) - unconditional transfer of US$20 per month to the main caregiver
Number of subjects: 14
Study 24454875 — intervention group
Group type: COMPARATOR
Intervention: Control group (households not receiving the cash transfer)
Number of subjects: 14
Study 22519919 — intervention group
Group type: EXPERIMENTAL
Intervention: Imeglimin 2000 mg once daily
Number of subjects: 0
Study 22519919 — intervention group
Group type: EXPERIMENTAL
Intervention: Imeglimin 1000 mg twice daily
Number of subjects: 0
Study 22519919 — intervention group
Group type: EXPERIMENTAL
Intervention: Imeglimin 500 mg twice daily
Number of subjects: 0
Study 22519919 — intervention group
Group type: EXPERIMENTAL
Intervention: Imeglimin 1500 mg twice daily
Number of subjects: 0
Study 22519919 — intervention group
Group type: COMPARATOR
Intervention: Metformin 850 mg twice daily
Number of subjects: 0
Study 22519919 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 20715737 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane plus remifentanil (1 microg/kg/minute intraoperatively)
Number of subjects: 60
Study 20715737 — intervention group
Group type: COMPARATOR
Intervention: Sevoflurane alone
Number of subjects: 60
Study 18294330 — intervention group
Group type: EXPERIMENTAL
Intervention: Itraconazole 200 mg
Number of subjects: 12
Study 18294330 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 15842055 — intervention group
Group type: EXPERIMENTAL
Intervention: TIS-assisted screening
Number of subjects: 10742
Study 12537186 — intervention group
Group type: EXPERIMENTAL
Intervention: Bovine heparin
Number of subjects: 207
Study 12537186 — intervention group
Group type: COMPARATOR
Intervention: Porcine heparin
Number of subjects: 207
Study 10619726 — intervention group
Group type: EXPERIMENTAL
Intervention: No specific therapy for funguria
Number of subjects: 861
Study 10619726 — intervention group
Group type: EXPERIMENTAL
Intervention: Catheter removal as the only treatment
Number of subjects: 861
Study 10619726 — intervention group
Group type: EXPERIMENTAL
Intervention: Antifungal therapy
Number of subjects: 861
Study 10619726 — intervention group
Group type: COMPARATOR
Intervention: Fluconazole
Number of subjects: 861
Study 10619726 — intervention group
Group type: COMPARATOR
Intervention: Amphotericin B bladder irrigation
Number of subjects: 861
Study 10619726 — intervention group
Group type: COMPARATOR
Intervention: Overall mortality rate
Number of subjects: 861
Study 8860389 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal beclomethasone for 8 weeks
Number of subjects: 31
Study 8860389 — intervention group
Group type: COMPARATOR
Intervention: Nasal cytology during winter
Number of subjects: 31
Study 8860389 — intervention group
Group type: COMPARATOR
Intervention: Nasal cytology during spring
Number of subjects: 31
Study 8860389 — intervention group
Group type: COMPARATOR
Intervention: Pathogenic organisms isolated
Number of subjects: 31
Study 8860389 — intervention group
Group type: COMPARATOR
Intervention: Atopy prevalence
Number of subjects: 31
Study 1300186 — intervention group
Group type: EXPERIMENTAL
Intervention: Early surgical treatment of contractures (release of hip flexors, removal of iliotibial bands, lengthening of tendo Achilles bilaterally)
Number of subjects: 20
Study 1300186 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgery
Number of subjects: 20
Study 30589829 — intervention group
Group type: COMPARATOR
Intervention: Supervised progressive resistance training (RT1)
Number of subjects: 65
Study 30589829 — intervention group
Group type: COMPARATOR
Intervention: Home-based resistance training (RT2)
Number of subjects: 65
Study 30589829 — intervention group
Group type: COMPARATOR
Intervention: Usual care control group (CON)
Number of subjects: 65
Study 29096686 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation for deficiency prior to THR/TKR for 6 months
Number of subjects: 100
Study 29096686 — intervention group
Group type: COMPARATOR
Intervention: No supplementation for patients with normal vitamin D levels (≥50 nmol/L)
Number of subjects: 100
Study 26458936 — intervention group
Group type: EXPERIMENTAL
Intervention: Respiratory training (RT) for COPD patients, delivered by a physiotherapist for a minimum of 1 hour per visit, with exercises performed at home at least 5 days per week for 12 months.
Number of subjects: 60
Study 26458936 — intervention group
Group type: COMPARATOR
Intervention: Routine health education provided by physiotherapists to the control group over the same period.
Number of subjects: 60
Study 23567348 — intervention group
Group type: EXPERIMENTAL
Intervention: Sutured transoral outlet reduction (TORe)
Number of subjects: 77
Study 23567348 — intervention group
Group type: COMPARATOR
Intervention: Sham procedure (control)
Number of subjects: 77
Study 20666879 — intervention group
Group type: EXPERIMENTAL
Intervention: SA+CDP
Number of subjects: 46
Study 20666879 — intervention group
Group type: EXPERIMENTAL
Intervention: all‐TRA+CDP
Number of subjects: 46
Study 19735404 — intervention group
Group type: EXPERIMENTAL
Intervention: i-gel
Number of subjects: 80
Study 19735404 — intervention group
Group type: COMPARATOR
Intervention: LMA-Unique
Number of subjects: 80
Study 18825439 — intervention group
Group type: EXPERIMENTAL
Intervention: Donepezil or Vitamin E (exact dosage and duration not specified)
Number of subjects: 152
Study 15830732 — intervention group
Group type: EXPERIMENTAL
Intervention: Gradual withdrawal treatment approaches
Number of subjects: 76
Study 15830732 — intervention group
Group type: EXPERIMENTAL
Intervention: Cluster B personality/borderline personality disorder
Number of subjects: 76
Study 15830732 — intervention group
Group type: COMPARATOR
Intervention: Alcohol use-related disorders or other psychiatric diagnoses
Number of subjects: 76
Study 12477583 — intervention group
Group type: EXPERIMENTAL
Intervention: Remifentanil (n = 1,229) 0.5 microg/kg/min for induction and tracheal intubation followed by an infusion rate of 0.25 microg/kg/min
Number of subjects: 2438
Study 12477583 — intervention group
Group type: COMPARATOR
Intervention: Fentanyl (n = 1,209) administered according to the anesthesiologist's usual practice
Number of subjects: 2438
Study 10512410 — intervention group
Group type: EXPERIMENTAL
Intervention: Preterm formula with arachidonic and docosahexaenoic acid
Number of subjects: 0
Study 10512410 — intervention group
Group type: COMPARATOR
Intervention: Preterm formula without arachidonic and docosahexaenoic acid
Number of subjects: 0
Study 10512410 — intervention group
Group type: EXPERIMENTAL
Intervention: Human breast milk
Number of subjects: 0
Study 7551961 — intervention group
Group type: EXPERIMENTAL
Intervention: Etoposide phosphate
Number of subjects: 0
Study 7551961 — intervention group
Group type: COMPARATOR
Intervention: Etoposide
Number of subjects: 0
Study 1935150 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen (600 mg iv or 800 mg iv over 20 mins, followed by three 800-mg doses rectally every 6 hrs)
Number of subjects: 29
Study 1935150 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study 6750166 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 683
Study 6750166 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide
Number of subjects: 683
Study 6750166 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide (in blacks)
Number of subjects: 683
Study 6750166 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide (in whites)
Number of subjects: 683
Study 30948695 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (DEX) administered in the preoperative and intraoperative periods
Number of subjects: 0
Study 30948695 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 26148587 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxitard capsules (2 capsules twice daily for 3 months)
Number of subjects: 120
Study 26148587 — intervention group
Group type: COMPARATOR
Intervention: Placebo (twice daily for 3 months)
Number of subjects: 120
Study 24463657 — intervention group
Group type: EXPERIMENTAL
Intervention: Robotic sacrocolpopexy
Number of subjects: 78
Study 24463657 — intervention group
Group type: COMPARATOR
Intervention: Laparoscopic sacrocolpopexy
Number of subjects: 78
Study 21295833 — intervention group
Group type: EXPERIMENTAL
Intervention: eLH (equine LH) administered intravenously every 12 h from the day the largest follicle reached 20 mm until a follicle reached >32 mm
Number of subjects: 14
Study 21295833 — intervention group
Group type: COMPARATOR
Intervention: Saline (transitional control) administered in the same manner as eLH
Number of subjects: 14
Study 21295833 — intervention group
Group type: EXPERIMENTAL
Intervention: hCG (3000 IU) administered after a follicle reached >32 mm
Number of subjects: 14
Study 21295833 — intervention group
Group type: COMPARATOR
Intervention: Transitional control and transitional eLH groups after hCG-induced ovulation
Number of subjects: 14
Study 21295833 — intervention group
Group type: COMPARATOR
Intervention: Circulating estradiol levels
Number of subjects: 14
Study 19420193 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.2% chlorhexidine
Number of subjects: 512
Study 19420193 — intervention group
Group type: COMPARATOR
Intervention: 0.01% potassium permanganate (control)
Number of subjects: 512
Study 19420193 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 512
Study 17665051 — intervention group
Group type: EXPERIMENTAL
Intervention: Valdecoxib (40 mg)
Number of subjects: 25
Study 17665051 — intervention group
Group type: COMPARATOR
Intervention: Piroxicam (20 mg)
Number of subjects: 25
Study 15270931 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard prolonged catheterisation (4 days post-operatively)
Number of subjects: 100
Study 15270931 — intervention group
Group type: COMPARATOR
Intervention: Not prolonged catheterisation (removed the morning after surgery)
Number of subjects: 100
Study 11528363 — intervention group
Group type: EXPERIMENTAL
Intervention: Workbook plus baseline and 6-month surveys
Number of subjects: 580
Study 11528363 — intervention group
Group type: EXPERIMENTAL
Intervention: Workbook and 6-month survey
Number of subjects: 580
Study 11528363 — intervention group
Group type: EXPERIMENTAL
Intervention: Workbook (combined with surveys)
Number of subjects: 580
Study 11528363 — intervention group
Group type: COMPARATOR
Intervention: No workbook with both surveys
Number of subjects: 580
Study 9749685 — intervention group
Group type: EXPERIMENTAL
Intervention: Macro electromyography (macro EMG)
Number of subjects: 18
Study 9749685 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrical stimulation
Number of subjects: 18
Study 7839259 — intervention group
Group type: EXPERIMENTAL
Intervention: Quinsy tonsillectomy (QT)
Number of subjects: 51
Study 7839259 — intervention group
Group type: COMPARATOR
Intervention: Interval tonsillectomy (IT)
Number of subjects: 51
Study 3049953 — intervention group
Group type: EXPERIMENTAL
Intervention: CNF (cyclophosphamide, mitoxantrone, fluorouracil)
Number of subjects: 331
Study 3049953 — intervention group
Group type: COMPARATOR
Intervention: CAF (cyclophosphamide, doxorubicin, fluorouracil)
Number of subjects: 331
Study 30041167 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based cognitive behavioral therapy (ICBT) for 12 weeks
Number of subjects: 100
Study 30041167 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 100
Study 26463567 — intervention group
Group type: COMPARATOR
Intervention: Compression bandaging with NSAIDs (C)
Number of subjects: 90
Study 26463567 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspiration (A)
Number of subjects: 90
Study 26463567 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspiration with steroid injection (AS)
Number of subjects: 90
Study 25604722 — intervention group
Group type: EXPERIMENTAL
Intervention: MILK diet (3.2 servings/d of 2% fat milk per 2000 kcal)
Number of subjects: 27
Study 25604722 — intervention group
Group type: COMPARATOR
Intervention: NCEP milk-free diet
Number of subjects: 27
Study 23992241 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidisciplinary depression management program (including activating strategies, psychotherapy, and medication)
Number of subjects: 33
Study 23992241 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidisciplinary depression management program
Number of subjects: 33
Study 23992241 — intervention group
Group type: EXPERIMENTAL
Intervention: Activating strategies
Number of subjects: 33
Study 23992241 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychotherapy
Number of subjects: 33
Study 23992241 — intervention group
Group type: COMPARATOR
Intervention: Pharmacological depression treatment
Number of subjects: 33
Study 20577017 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma exchange (PE)
Number of subjects: 32
Study 20577017 — intervention group
Group type: COMPARATOR
Intervention: Standard immunosuppressive therapy (prednisolone and cyclophosphamide)
Number of subjects: 32
Study 20577017 — intervention group
Group type: EXPERIMENTAL
Intervention: Change from cyclophosphamide (CYC) to cyclosporine A (CyA)
Number of subjects: 32
Study 18410941 — intervention group
Group type: EXPERIMENTAL
Intervention: Endocapsule (EC)
Number of subjects: 51
Study 18410941 — intervention group
Group type: COMPARATOR
Intervention: Pillcam SB (PSB)
Number of subjects: 51
Study 17147119 — intervention group
Group type: EXPERIMENTAL
Intervention: Involved-field irradiation (IFI)
Number of subjects: 200
Study 17147119 — intervention group
Group type: COMPARATOR
Intervention: Elective node irradiation (ENI)
Number of subjects: 200
Study 12187444 — intervention group
Group type: EXPERIMENTAL
Intervention: Monitoring condition
Number of subjects: 60
Study 12187444 — intervention group
Group type: EXPERIMENTAL
Intervention: ABX condition
Number of subjects: 60
Study 12187444 — intervention group
Group type: COMPARATOR
Intervention: Free recall condition
Number of subjects: 60
Study 12187444 — intervention group
Group type: EXPERIMENTAL
Intervention: All conditions
Number of subjects: 60
Study 10491487 — intervention group
Group type: EXPERIMENTAL
Intervention: Eradication therapy with pantoprazole 40 mg b.i.d., clarithromycin 500 mg b.i.d., and amoxicillin 1 g b.i.d. for 7 or 14 days
Number of subjects: 16
Study 9005796 — intervention group
Group type: EXPERIMENTAL
Intervention: Ofloxacin administered intravenously during the first days of treatment, followed by oral use
Number of subjects: 15
Study 1820900 — intervention group
Group type: EXPERIMENTAL
Intervention: Lansoprazole (30 mg) alone
Number of subjects: 12
Study 1820900 — intervention group
Group type: EXPERIMENTAL
Intervention: Lansoprazole with standard meal
Number of subjects: 12
Study 1820900 — intervention group
Group type: EXPERIMENTAL
Intervention: Lansoprazole with antacids (aluminium and magnesium hydroxides)
Number of subjects: 12
Study 1820900 — intervention group
Group type: EXPERIMENTAL
Intervention: Lansoprazole administered one hour after antacids
Number of subjects: 12
Study 7091770 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentaerythritol Tetranitrate (Peritrate) 40 mg chew-and-swallow tablets
Number of subjects: 10
Study 30082141 — intervention group
Group type: EXPERIMENTAL
Intervention: Citalopram 4 mg (low group)
Number of subjects: 45
Study 30082141 — intervention group
Group type: EXPERIMENTAL
Intervention: Citalopram 16 mg (high group)
Number of subjects: 45
Study 30082141 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study 26787345 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous epidural infusion analgesia (ED) with 0.2% Ropivacaine
Number of subjects: 94
Study 26787345 — intervention group
Group type: COMPARATOR
Intervention: IV PCA (Fentanyl)
Number of subjects: 94
Study 25591969 — intervention group
Group type: EXPERIMENTAL
Intervention: Higenamine
Number of subjects: 48
Study 25591969 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine
Number of subjects: 48
Study 25591969 — intervention group
Group type: EXPERIMENTAL
Intervention: Higenamine + Caffeine + Yohimbe bark extract
Number of subjects: 48
Study 25591969 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study 23095007 — intervention group
Group type: EXPERIMENTAL
Intervention: estradiol valerate in combination with testosterone undecanoate
Number of subjects: 50